Literature DB >> 24113260

Comparison of influenza virus yields and apoptosis-induction in an adherent and a suspension MDCK cell line.

B Peschel1, S Frentzel, T Laske, Y Genzel, U Reichl.   

Abstract

Cell culture-based manufacturing of influenza vaccines is ideally based on easily scalable platforms using suspension cells that grow in chemically defined media. Consequently, different adherent cell lines selected for high virus yields were adapted to grow in suspension culture. This includes the MDCK suspension cell line MDCK.SUS2, which was shown to be a suitable substrate for influenza virus propagation in previous studies. In this study, we investigated options for further improvement of influenza A/PR/8 (H1N1) virus titres and cell-specific virus yields. Best results were achieved by performing a 1:2 dilution with fresh medium at time of infection. In shake flask cultivations, even for multiplicities of infection as low as 10⁻⁵, all cells were infected at 36 h post infection as determined by flow cytometry. In addition, these cells showed a better viability than cells infected without previous washing steps, which was reflected by a reduced level of apoptotic cells, and virus yields exceeding 3 log₁₀ HAU/100 μL. Comparison of bioreactor infections of MDCK.SUS2 cells to the parental adherent MDCK cells showed similar HA titres of 2.94 and 3.15 log₁₀ HAU/100 μL and TCID₅₀ of 1 × 10⁹ and 2.37 × 10⁹ infectious virions/mL. Surprisingly, virus-induced apoptosis differed between the two cell lines, with the MDCK.SUS2 cells showing a much stronger apoptosis induction than the adherent MDCK cells. Obviously, despite their resistance to anoikis, the suspension cells were more susceptible to virus-induced apoptosis. Whether this is related to the adaptation process itself and/or to changes in cell survival pathways influenced by adhesion molecules or influenza virus proteins needs to be clarified in additional studies.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  1:2 dilution at toi; 1:2dil; 50% tissue culture infective dose; A/PR/8; A/Puerto Rico/8/34; CEACAM6; EMA; European medicines agency; FDA; FITC; Flow cytometry; Food and Drug Administration; GMEM; Glasgow minimum essential medium; HA; Influenza; MAD; MDCK; MDCK suspension cells; MOI; Madin–Darby canine kidney; Medium exchange; PI3K; TCID(50); TUNEL; TdT dUTP nick end labelling; Trypsin activity; Vaccine; carcinoembryonic antigen-related cell adhesion molecule 6; fluorescein isothiocyanate; haemagglutinin; hours post infection; hpi; median of absolute deviation; multiplicity of infection; phosphatidylinositide 3-kinase; time of infection; toi; w/oME; wME; with medium exchange; without medium exchange

Mesh:

Year:  2013        PMID: 24113260     DOI: 10.1016/j.vaccine.2013.09.051

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Semliki Forest Virus replicon particles production in serum-free medium BHK-21 cell cultures and their use to express different proteins.

Authors:  Sandra Fernanda Suárez-Patiño; Thaissa Consoni Bernardino; Eutimio Gustavo Fernández Núñez; Renato Mancini Astray; Carlos Augusto Pereira; Hugo R Soares; Ana S Coroadinha; Soraia Attie Calil Jorge
Journal:  Cytotechnology       Date:  2019-08-17       Impact factor: 2.058

2.  Overcoming nutrient limitations for cell-based production of influenza vaccine.

Authors:  Xu-Ping Liu; Ding Huang; Wen-Song Tan; Jian Luo; Ze Chen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Cell culture-based production of defective interfering particles for influenza antiviral therapy.

Authors:  Milena A Wasik; Luca Eichwald; Yvonne Genzel; Udo Reichl
Journal:  Appl Microbiol Biotechnol       Date:  2017-12-05       Impact factor: 4.813

4.  Tandem mass tag-based quantitative proteomic analysis of lycorine treatment in highly pathogenic avian influenza H5N1 virus infection.

Authors:  Li Yang; Jia Hao Zhang; Xiao Li Zhang; Guang Jie Lao; Guan Ming Su; Lei Wang; Yao Lan Li; Wen Cai Ye; Jun He
Journal:  PeerJ       Date:  2019-10-02       Impact factor: 2.984

5.  Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the "von Magnus effect".

Authors:  Felipe Tapia; Daniel Wohlfarth; Volker Sandig; Ingo Jordan; Yvonne Genzel; Udo Reichl
Journal:  PLoS One       Date:  2019-11-05       Impact factor: 3.240

6.  High cell density perfusion process for high yield of influenza A virus production using MDCK suspension cells.

Authors:  Yixiao Wu; Thomas Bissinger; Yvonne Genzel; Xuping Liu; Udo Reichl; Wen-Song Tan
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-30       Impact factor: 4.813

7.  Tracking changes in adaptation to suspension growth for MDCK cells: cell growth correlates with levels of metabolites, enzymes and proteins.

Authors:  Sabine Pech; Markus Rehberg; Robert Janke; Dirk Benndorf; Yvonne Genzel; Thilo Muth; Albert Sickmann; Erdmann Rapp; Udo Reichl
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-13       Impact factor: 4.813

8.  Characterization and Immunogenicity of Influenza H7N9 Vaccine Antigens Produced Using a Serum-Free Suspension MDCK Cell-Based Platform.

Authors:  Min-Yuan Chia; Chun-Yang Lin; Po-Ling Chen; Chia-Chun Lai; Tsai-Chuan Weng; Wang-Chou Sung; Alan Yung-Chih Hu; Min-Shi Lee
Journal:  Viruses       Date:  2022-08-31       Impact factor: 5.818

9.  Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines.

Authors:  Ding Huang; Wen-Juan Peng; Qian Ye; Xu-Ping Liu; Liang Zhao; Li Fan; Kang Xia-Hou; Han-Jing Jia; Jian Luo; Lin-Ting Zhou; Bei-Bei Li; Shi-Lei Wang; Wen-Ting Xu; Ze Chen; Wen-Song Tan
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.